Twenty-four percent of melanoma patients carry MC1R loss-of-function variants, and although redheads who express two MC1R loss-of-function alleles comprise only 1–2% of the worldwide population, they represent 16% of all melanoma patients [74,75]. This evidence concerns the gene MC1R and melanoma.